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JOOST P. VAN MELLE, MD, PHD3
PETER DE JONGE, PHD1,2
OBJECTIVEdDiabetes and depression are both linked to an increased mortality risk after
myocardial infarction (MI). Population-based studies suggest that having both diabetes and
depression results in an increased mortality risk, beyond that of having diabetes or depression
alone. The purpose of this study was to examine the joint association of diabetes and depression
with mortality in MI patients.
RESEARCH DESIGN AND METHODSdData were derived from two multicenter co-
hort studies in the Netherlands, comprising 2,704 patients who were hospitalized for MI. De-
pression, deﬁned as a Beck Depression Inventory score$10, and diabetes were assessed during
hospitalization. Mortality data were retrieved for 2,525 patients (93%).
RESULTSdDuring an average follow-up of 6.2 years, 439 patients died. Themortality rate was
14% (226 of 1,673) in patients without diabetes and depression, 23% (49 of 210) in patients with
diabetes only, 22% (118 of 544) in patients with depression only, and 47% (46 of 98) in patients
with both diabetes and depression. After adjustment for age, sex, smoking, hypertension, left
ventricular ejection fraction, prior MI, and Killip class, hazard ratios for all-cause mortality were
1.38 (95% CI 1.00–1.90) for patients with diabetes only, 1.39 (1.10–1.76) for patients with
depression only, and asmuch as 2.90 (2.07–4.07) for patients with both diabetes and depression.
CONCLUSIONSdWe observed an increased mortality risk in post-MI patients with both
diabetes and depression, beyond the association with mortality of diabetes and depression alone.
Diabetes Care 35:503–509, 2012
Myocardial infarction (MI) is an im-portant cause of morbidity andmortality worldwide (1). Major
depression after MI is present in ;20%
of all MI patients (2). A meta-analysis
showed that depression is associated with
an almost 2.5-fold increased risk for mor-
tality in post-MI patients, independent
from other established risk factors for mor-
tality (3). Likewise, diabetes is common in
MI patients and is independently associ-
ated with increased risk for cardiovascular
morbidity (4) and mortality (5,6).
Depression and diabetes are known
to interact in the general population, and
their combination results in poor health
outcomes. The prevalence of depression
is high in patients with diabetes, affecting
;18% of type 2 diabetic patients (7). De-
pression can impair diabetes management
and diabetes outcomes through behavioral
or biological pathways (8). For example,
depression appeared to be associated with
less optimal diabetes self-care behaviors
and subsequent poor glycemic control
(9). In addition, depression was related
to hypothalamic-pituitary-adrenocortical
hyperactivity, which subsequently can af-
fect glucose metabolism (10). It has also
been proposed that diabetes and depres-
sion may share a common underlying
pathogenesis (8). Among diabetic patients,
several studies show that depression is an
independent risk factor for an increased
risk of mortality (11–14). Moreover, stud-
ies in the general population suggest a syn-
ergistic, additive interaction between
diabetes and depression on mortality
(8,15–17) (e.g., that having both diabetes
and depression results in an increased
mortality risk, beyond that of having di-
abetes or depression alone).
The association of the coexistence of
diabetes and depression with mortality
has not been investigated in patients who
had a recent MI, which are patients with a
high mortality risk. Hence, the aim of
this study is to investigate whether the
coexistence of diabetes and depression is
associated with increased risk of all-cause
and cardiac mortality in patients who had
an MI, beyond the risks associated with
diabetes and depression alone.
RESEARCH DESIGN AND
METHODSdData were derived from
the Depression and Myocardial Infarction
Study (DepreMI) (18) and the Myocardial
Infarction and Depression-Intervention
Trial (MIND-IT) (19). In these multicen-
ter studies, 528 and 2,176 MI patients,
respectively, were screened for depres-
sion. Patients were recruited from 14 hos-
pitals (including 4 university hospitals)
located in different parts of theNetherlands.
Patients were included from September
1997 through September 2000 in Dep-
reMI and from October 1999 through
November 2002 in MIND-IT if they met
established criteria for MI (20). Exclusion
criteria were cognitive dysfunction, not
being able to speak or read Dutch, hospi-
talization for other reasons than MI
(except angina pectoris), and a life expec-
tancy of,1 year as a result of noncardio-
vascular disease. In MIND-IT, patients
were also excluded if they were already
receiving psychiatric treatment for a cur-
rent depressive episode (n = 104). Because
the two studies were highly comparable
in patient recruitment, inclusion and ex-
clusion criteria, and depression assessment,
data of both studies were combined for the
present analyses. Both studies were ap-
proved by the local ethical committee of
the participating hospitals, and all patients
gave informed consent.
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Measurements
Depression and diabetes. In patients
who were hospitalized for index-MI, we
assessed depression with the 21-item Beck
Depression Inventory (BDI), using BDI
scores $10 to indicate depression. The
BDI is a validated instrument for depres-
sion, and BDI scores$10 are considered
to signify at least mild depression (21).
The presence of diabetes was based on
either self-reported diagnosis at admis-
sion, which was veriﬁed by the medical
chart, or a new diagnosis at discharge for
which medication was necessary. This in-
formation was collected during hospital-
ization for index-MI.
Mortality. The primary outcome was all-
cause mortality. Mortality records up un-
til 31 December 2007 were provided by
Statistics Netherlands through linkage to
theMunicipal Personal Records Database.
We calculated time to mortality from the
index-MI to date of death. Survivors were
censored at 31 December 2007. Second-
ary outcome was death from cardiac dis-
ease as primary cause of death (cardiac
mortality), based on ICD-10 (codes I11,
I20–I25, I42–I50, and R57.0) in the mor-
tality records. For this outcome, survivors
were censored at 31 December 2007. Pa-
tients who died for noncardiac reasons
were censored at the date of death.
Covariates. Demographic, lifestyle, and
cardiovascular data were collected during
hospitalization for index-MI and included
age, sex, smoking status, hypertension,
left ventricular ejection fraction (LVEF),
prior MI, and Killip class. Smoking was
deﬁned as current smoking or cessation of
smoking ,3 months ago. Information
about hypertension was derived from
the medical chart. LVEF was assessed by
either echocardiography or radionuclide
ventriculography. Killip class was deter-
mined at hospital admission, with a stan-
dardized 4-point clinical assessment of
the degree of heart failure, based on pul-
monary rales and X-ray. Killip class was
divided in two categories (class 1 and
class 2, 3, or 4).
Statistical analysis
We classiﬁed the patients according to
their diabetes and depression status into
the following four categories: 1) no diabe-
tes, no depression; 2) diabetes, no depres-
sion; 3) no diabetes, depression; and
4) diabetes, depression. First, we evalu-
ated withmultinomial regressionwhether
baseline characteristics for groups 2 to 4
differed signiﬁcantly from group 1 (no di-
abetes, no depression). Next, we assessed
time to all-cause and cardiac mortality us-
ing Cox regression models, in a crude
model, and after adjusting for a priori de-
ﬁned covariates, in a stepwise approach:
1) age and sex; 2) age, sex, hypertension,
and smoking; and 3) age, sex, hyperten-
sion, smoking, LVEF, prior MI, and Killip
class. The group without diabetes and
depression served as reference group. To
illustrate the relationships between de-
pression and diabetes with mortality, we
plotted Kaplan-Meier curves for each di-
abetes and depression category. Further-
more, we tested whether biological
interaction had occurred. Biological inter-
action refers to a deviation from additivity
of two or more causes of disease that to-
gether inﬂuence the disease outcome (22).
In Cox regression analysis, biological in-
teraction differs from statistical interaction
because in Cox regression models, statis-
tical interaction is implicitly exponential
and therefore multiplicative. We tested
whether biological interaction had oc-
curred using the Relative Excess Risk due
to Interaction (RERI) (22) by using the
method outlined by Andersson et al. (23).
RERI represents the risk that is in excess of
what would be expected if the combina-
tion of two risk factors would be purely
additive (e.g., no synergism). An RERI.0
indicates a synergistic, additive inter-
action. We adjusted for the same sets of
covariates as described for the Cox regres-
sion models.
Missing values for the variables used
in the statistical analyses were assumed to
be missing at random and were multiply
imputed using imputation by chained
equations. Ten imputed datasets were
created. Variables used to impute datasets
were diabetes, log-transformed BDI score
at baseline, log-transformed BDI score at 3
months, factor scores for somatic/affective
depressive symptoms and cognitive/affec-
tive depressive symptoms, mortality, log-
transformed time to mortality, age, sex,
hypertension, smoking, LVEF, prior MI,
Killip class, BMI, study, location of MI,
hypercholesterolemia, family history of
coronary artery disease, rehospitalization,
and log-transformed time to rehospitali-
zation. The numbers and hazard ratios
(HRs) reported in this studywere based on
the multiply imputed datasets. HRs from
the imputed datasets were combined us-
ing Rubin’s rules (24). The numbers were
averaged over the 10 imputed datasets.
Although mortality data were used to cre-
ate the imputed datasets, cases with im-
puted mortality data were excluded from
theCox regression analysis as recommended
byvonHippel (25).We alsodid an available-
case analysis in which we repeated the Cox
regression analysis with the existing data.
We tested statistical interaction between
depression and diabetes for mortality by
testing the signiﬁcance of the interaction
term depression-diabetes as a supplemen-
tary analysis. Analyses were performed in
STATA 10.1 (StataCorp., College Station,
TX). A two-sided a of 0.05 was used to
indicate statistical signiﬁcance.
RESULTSdFrom the 2,704 patients in
the dataset, 2,111 (78%) were men. The
mean age at baseline was 61 years (SD 12).
Missing data of depression and diabetes
were multiply imputed for 236 patients
(9%) and 15 patients (,1%), respec-
tively. At baseline, 1,789 patients (66%)
had no diabetes and no depression, 224
patients (8%) had diabetes but no depres-
sion, 585 patients (22%) had depression
but no diabetes, and 106 patients (4%)
had both diabetes and depression. Table 1
presents the baseline characteristics across
these four categories. Those with both di-
abetes and depressionwere on average less
healthy and had a worse cardiovascular
risk proﬁle but were less often current
smokers than patients without diabetes
and depression. Table 1 also shows the
percentage of missing values that were im-
puted per baseline variable, which varied
between 0 and 9%.
For 179 patients (7%), data on mor-
tality could not be retrieved. These pa-
tients were therefore excluded from the
Cox regression analyses. Additional anal-
yses showed that these patients did not
differ from those with mortality data re-
garding presence of depression, diabetes,
and the other covariates, except for prior
MI. There was a higher prevalence of prior
MI in patients whose mortality data could
not be retrieved (21 vs. 14%, P = 0.005).
Of the remaining 2,525 patients with data
on mortality, a total of 439 participants
(17%) died during follow-up, of which
175 (7%) were classiﬁed as cardiac death.
The all-cause mortality rate was 14% (226
of 1,673) for patients without depression
and without diabetes, 23% (49 of 210) for
patients with diabetes only, 22% (118 of
544) for patients with depression only,
and 47% (46 of 98) for patients with
both depression and diabetes. The mean
follow-up time for the participants was
6.2 years (SD 2.0).
Figures 1 and 2 show the Kaplan-
Meier curves for all-cause and cardiac
mortality for each strata of diabetes and
depression. Table 2 shows the number
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of deaths and the HRs for all-cause and
cardiac mortality across the four catego-
ries of diabetes and depression. Patients
who had both diabetes and depression
had a considerably higher HR for mortal-
ity. For all-cause mortality, the HR was
4.58 (95% CI 3.29–6.37) for the patients
with both diabetes and depression in the
unadjusted analyses compared with the
reference group (patients without dia-
betes and without depression). The
strength of the relationship with mortal-
ity decreased to some extent after adjust-
ment for the potential confounders (age,
sex, smoking, hypertension, LVEF, pre-
vious MI, and Killip class) but remained
signiﬁcant. Furthermore, post hoc com-
parisons showed that the HR in those
with both diabetes and depression was
higher compared with patients with di-
abetes only (full model: 2.10 [1.38–
3.21]) and depression only (full model:
2.08 [1.46–2.98]). The association be-
tween diabetes, depression, and mortal-
ity did not differ by sex; the interaction
terms of the diabetes depression catego-
ries with sex were not statistically signif-
icant. The HR for cardiac mortality in the
diabetes and depression group was 5.77
(3.53–9.43) in the unadjusted model
and 3.27 (1.97–5.41) in the fully ad-
justed model. Post hoc comparisons
showed that the HR in patients with
both diabetes and depression was higher
compared with patients with diabetes
only (full model: 2.54 [1.32–4.89]) and
depression only (full model: 2.10 [1.25–
3.54]).
Whenwe repeated the Cox regression
analysis as an available-case analysis in the
nonimputed dataset, approximately sim-
ilar results were found (data not shown).
For example, the HR for all-cause mor-
tality in the fully adjusted model was 1.37
(95% CI 0.95–1.98) for those with diabe-
tes only, 1.32 (1.02–1.71) for those with
depression only, and 3.23 (2.25–4.64) for
those with both diabetes and depression
compared with those without diabetes and
depression in the available-case analysis.
Biological interaction
For all-cause mortality, the RERI was 1.94
(95% CI 0.37–3.51) in the unadjusted
analyses and 1.13 (0.12–2.14) in the fully
adjusted analyses. This exceeds the value
0 and, thus, suggests a positive interaction











P values 1 vs. 2;
1 vs. 3; 1 vs. 4*
n 1,789 224 585 106 250 (9.2)†
Age, years (mean 6 SD) 60.4 6 11.7 64.7 6 10.6 61.3 6 12.8 65.5 6 11.0 2 (,0.1)† ,0.001; 0.143; ,0.001
BMI, kg/m2 (mean 6 SD) 26.5 6 3.8 27.8 6 4.3 26.1 6 4.0 27.5 6 4.4 162 (6.0)† ,0.001; 0.064; 0.012
Male 1,447 (80.9) 161 (71.9) 432 (73.8) 71 (67.0) 0 (0)† 0.003; ,0.001; 0.001
Study 0.218; 0.419; 0.138
MIND-IT 1,424 (79.6) 186 (83.0) 475 (81.2) 91 (85.8) 0 (0)†
DepreMI 365 (20.4) 38 (17.0) 110 (18.8) 15 (14.2) 0 (0)†
Current smoker 899 (50.3) 77 (34.4) 301 (51.5) 32 (30.2) 107 (4.0)† ,0.001; 0.658; ,0.001
Hypertension 533 (29.8) 105 (46.9) 192 (32.8) 50 (47.2) 18 (0.7)† ,0.001; 0.189; ,0.001
Hypercholesterolemia 1,205 (67.4) 150 (67.0) 400 (68.4) 80 (75.5) 20 (0.7)† 0.866; 0.678; 0.087
Family history of
coronary artery disease 801 (44.8) 81 (36.2) 256 (43.8) 36 (34.0) 51 (1.9)† 0.018; 0.709; 0.042
Peripheral vascular disease 111 (6.2) 24 (10.9) 60 (10.4) 23 (22.1) 23 (0.9) 0.013; 0.001; ,0.001
Cerebrovascular disease 83 (4.7) 16 (7.3) 43 (7.5) 15 (14.4) 26 (1.0) 0.085; 0.012; ,0.001
Thrombolysis 691 (39.0) 75 (33.9) 221 (38.3) 28 (27.2) 30 (1.1) 0.155; 0.771; 0.019
Percutaneous intervention during
hospitalization for index-MI 643 (37.6) 49 (23.3) 203 (36.7) 40 (38.5) 126 (4.7) ,0.001; 0.725; 0.883
Coronary artery bypass graft during
hospitalization for index-MI 81 (4.7) 17 (8.1) 21 (3.8) 6 (5.8) 130 (4.8) 0.056; 0.375; 0.803
Localization MI anterior 572 (32.0) 81 (36.2) 208 (35.6) 40 (37.7) 0 (0)† 0.210; 0.124; 0.195
Killip class 65 (2.4)† ,0.001; 0.009; ,0.001
1 1,618 (90.4) 182 (81.2) 505 (86.3) 81 (76.4)
2, 3, or 4 171 (9.6) 42 (18.8) 80 (13.7) 25 (23.6)
LVEF (%)‡ 189 (7.0)† ,0.001; ,0.001; ,0.001
$45 1,400 (78.3) 145 (64.7) 414 (70.8) 59 (55.7)
,45 389 (21.7) 79 (35.3) 171 (29.2) 47 (44.3)
Previous MI before study 218 (12.2) 45 (20.1) 93 (15.9) 26 (24.5) 21 (0.8)† 0.002; 0.034; 0.001
Acetylsalicylic acid 1,513 (86.4) 178 (82.8) 475 (82.9) 77 (74.8) 61 (2.3) 0.148; 0.047; 0.004
b-Blockers 1,511 (84.9) 183 (83.2) 471 (80.9) 73 (70.9) 19 (0.7) 0.511; 0.028; 0.001
Calcium antagonist 297 (17.0) 48 (22.3) 114 (19.9) 30 (29.1) 61 (2.3) 0.064; 0.123; 0.004
Diuretics 222 (12.5) 45 (20.5) 106 (18.2) 39 (37.9) 19 (0.7) 0.001; 0.001; ,0.001
ACE inhibitor 704 (39.6) 109 (49.5) 239 (41.1) 42 (40.8) 19 (0.7) 0.005; 0.541; 0.801
Statin/lipid-lowering drug 1,272 (71.5) 145 (65.9) 392 (67.4) 67 (65.0) 19 (0.7) 0.079; 0.065; 0.158
Data are n (%) unless noted otherwise. *1 vs. 2: no diabetes, no depression vs. diabetes, no depression. 1 vs. 3: no diabetes, no depression vs. depression, no diabetes.
1 vs. 4: no diabetes, no depression vs. diabetes, depression. †These variables were part of the imputation model and missing values are therefore multiply imputed;
multiply imputed data for these variables are shown. ‡LVEF in the DepreMI: cutoff on 40% (n = 528).
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between diabetes and depression as de-
parture from additivity. This means that
the joint effect of diabetes and depression
is signiﬁcantly larger than the sum of the
individual effects of diabetes and depres-
sion, even after controlling for confound-
ers. For cardiacmortality, there was a trend
for a positive additive interaction between
diabetes and depression, but this was not
statistically signiﬁcant (unadjusted analy-
sis: 2.90 [20.02 to 5.82]; fully adjusted
analysis: 1.42 [20.21 to 3.06]).
Supplemental analyses
We tested formal statistical (multiplica-
tive) interaction between depression and
diabetes for mortality. Although the di-
rection of the multiplicative interaction
was positive, this interaction was not sig-
niﬁcant for all-cause mortality (range P =
0.10–0.20 across the models) and cardiac
mortality (range P = 0.21–0.30 across the
models).
CONCLUSIONSdThis is the ﬁrst
study that aimed to investigate the asso-
ciation of coexisting diabetes and depres-
sion with mortality after MI. We observed
an increased mortality risk in patients
with both diabetes and depression who
were hospitalized for MI, beyond the
association with mortality for diabetes
and depression alone. This association
weakened somewhat but remained statis-
tically signiﬁcant after adjustment for de-
mographic and established prognostic
cardiac factors. Most striking, there was
a synergistic additive interaction between
diabetes and depression for mortality,
which weakened but remained statisti-
cally signiﬁcant after adjusting for car-
diac disease severity. Our results are
similar to population-based, epidemio-
logical studies that suggest a possible
synergistic interaction between diabetes
and depression or psychological distress
for mortality (8,15–17,26). Although
the absolute mortality rate in this high-
risk group for mortality was considerably
higher, the strength of the association
of diabetes and depression with mor-
tality is within the range of associations
observed in the population-based
studies.
Several explanations might be sug-
gested for our results. First, depression
might aggravate the course of diabetes in
MI patients. It is known that diabetic
patients with depression have more di-
abetes-related complications (such as di-
abetic retinopathy, nephropathy, and
neuropathy) (27) and are more often in
poor glycemic control, as denoted by ele-
vated levels of glycated hemoglobin
(HbA1c) (28), than diabetic patients with-
out depression. In a population study of
people with psychological distress and di-
abetes, elevated HbA1c levels did not ex-
plain the increased mortality risk (26). On
the other hand, HbA1c levels appeared to
be related to mortality in a study with MI
patients, both in nondiabetic patients and
in diabetic patients (29). Depression is
known to be related to a reduced adher-
ence to self-care behaviors (i.e., diet, exer-
cise, and smoking cessation) and to
reduced medication adherence in dia-
betic as well as MI patients (30,31). Not
only major depression but also sub-
threshold depression is associated with
Figure 1dKaplan-Meier curves for all-cause mortality for each diabetes and depression cate-
gory (unadjusted analysis).
Figure 2dKaplan-Meier curves for cardiac mortality for each diabetes and depression category
(unadjusted analysis).
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nonadherence to different aspects of dia-
betes self-care (32). For MI patients with
diabetes, poorer self-care might be more
deleterious compared with MI patients
without diabetes because of the many
and often complex self-care activities in-
volved in diabetes management. Further-
more, depression is related to several
biological changes, such as increased in-
ﬂammation and dysfunction of the auto-
nomic nervous system, which in turn
are related to increased cardiovascular
mortality (33).
Second, we found that part of the
excess risk associated with the coexistence
of diabetes and depression was explained
by the baseline cardiac disease severity
parameters. Speciﬁcally, patients with
both diabetes and depression had worse
physical health to start with, such as more
peripheral vascular disease and cerebro-
vascular disease. It is unclear whether this
represents confounding (i.e., that depres-
sion and diabetes may serve as a risk
indicator for MI patients with a poor
clinical proﬁle) or whether this is already a
consequence of the diabetes-depression
interaction. A possible explanation for
these ﬁndings rests on the premise that
depressionmay have a different etiology in
diabetic patients compared with patients
without diabetes. Diabetes and depres-
sion share several metabolic alterations in
proinﬂammatory cytokines, glucocorti-
coid signaling, and cellular respiration
(34). The combination of diabetes and de-
pression in MI patients might be an ex-
pression of such metabolic alterations
and may therefore be associated with a
poorer cardiac prognosis. This is in line
with the many reports on the association
of proinﬂammatory cytokines with the de-
velopment and progression of a cardiac
disease, including increased mortality
risk (35,36).
What are the clinical implications of
our ﬁndings? In the next decades, an
immense increase in the prevalence of
type 2 diabetes is expected to occur.
Because the prevalence of depression in
patients with type 2 diabetes is almost
twice that of nondiabetic people (7), both
diabetes and depression will become
highly prevalent health problems in MI
patients. Physicians should be aware
that MI patients with diabetes and depres-
sion have an increased mortality risk.
Therefore, it may be relevant to identify
patients at risk with screening. However,
there is an ongoing debate whether
screening for depression will beneﬁt the
patients’ prognosis. Although identiﬁca-
tion can be useful, there are no studies
showing that screening alone improves
depressive symptoms and cardiac out-
comes (37) or diabetes outcomes (38) in
patients with cardiovascular disease or di-
abetes, respectively. Recently, a nurse-led
collaborative care management for pri-
mary care patients with poorly controlled
diabetes and/or coronary artery disease
and depression was evaluated (39). The
intervention group had improved with re-
spect to blood pressure, HbA1c, and de-
pression after 12 months, which are
factors that are known to be related to in-
creased mortality (39). It may be worth-
while to monitor MI patients with both
diabetes and depression closely to evalu-
ate their mood, adherence to treatment
regimens, and compliance with lifestyle
recommendations, such as enhancing
physical activity. Likewise, prevention of
the onset of diabetes and depressionmight
be important. Furthermore, in our study,
we had a relatively low prevalence of di-
abetes. It might be relevant to investigate
whether our results can be replicated in
countries with a higher prevalence of di-
abetes in MI patients.
Strengths and limitations
Several strengths and weaknesses of this
study should be acknowledged in inter-
preting our ﬁndings. First, our large co-
hort of MI patients and long follow-up
period made it possible to study the effect
of the coexistence of diabetes and de-
pression on mortality. Second, both de-
mographic and cardiac risk factors were
included as confounders. Finally, by
merging our data with the national mor-
tality records, reliable and high-quality
data of the primary cause of death could be
retrieved. A limitation of our study was the
use of depression questionnaires instead
of diagnostic interviews. However, the
BDI has been validated in MI patients
against a structural clinical interview for
depression (40). In MIND-IT, patients
with psychiatric treatment for depression
during screening were excluded. This re-
duced the number of depressed patients in
our study. Furthermore, depression was
measured during hospitalization, and we
did not have data on lifetime depression
for the majority of our patients. The pres-
ence of diabetes was not systematically
tested according to a prespeciﬁed labora-
tory protocol. Therefore, some patients
with MI might have had undetected dia-
betes. Others might have been incorrectly
designated as a diabetic patient. This
might have inﬂuenced our associations
with mortality. Furthermore, for 7% of
the sample, data on mortality were not
available. In addition, the ratio of cardiac
deaths per covariate is small. This in-
creases the risk of overﬁtting. We there-
fore showed several models where we
adjusted for covariates in a stepwise ap-
proach. Finally, we did not assess other
relevant diabetes-related aspects (HbA1c
and diabetes complications) or self-care
behaviors (physical activity and medica-
tion adherence) that might help to explain
our ﬁndings.
To conclude, we found that the co-
existence of diabetes and depression after
MI is related to increased mortality, be-
Table 2dNumber of deaths and HRs for all-cause and cardiac mortality for the four










Number of deaths* 226 of 1,673 49 of 210 118 of 544 46 of 98
Unadjusted 1.00 1.89 (1.38–2.60) 1.75 (1.39–2.20) 4.58 (3.29–6.37)
Model 1 1.00 1.56 (1.13–2.15) 1.63 (1.29–2.06) 3.78 (2.71–5.28)
Model 2 1.00 1.58 (1.15–2.17) 1.61 (1.27–2.03) 3.79 (2.71–5.29)
Model 3 1.00 1.38 (1.00–1.90) 1.39 (1.10–1.76) 2.90 (2.07–4.07)
Cardiac mortality
Number of deaths* 84 of 1,673 18 of 210 51 of 544 22 of 98
Unadjusted 1.00 1.86 (1.07–3.24) 2.01 (1.39–2.92) 5.77 (3.53–9.43)
Model 1 1.00 1.58 (0.91–2.76) 1.92 (1.32–2.80) 4.97 (3.02–8.18)
Model 2 1.00 1.58 (0.91–2.76) 1.90 (1.30–2.76) 4.91 (2.98–8.09)
Model 3 1.00 1.29 (0.75–2.22) 1.56 (1.07–2.26) 3.27 (1.97–5.41)
Data are HR (95% CI) unless noted otherwise. Model 1: adjusted for age and sex. Model 2: adjusted for age,
sex, smoking, and hypertension. Model 3: adjusted for age, sex, smoking, hypertension, previous MI, Killip
class, and LVEF. *Using multiple imputation for missing values. Missing data for mortality are not multiply
imputed.
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